Pharma Stocks Under ₹200

It's important to note that specific stock recommendations cannot be provided here. However, you can use online resources like INDmoney's stock screeners or financial websites to find a list of pharma stocks trading under ₹200. Remember, conduct your own research before investing in any particular company.

These stocks typically carry higher risk compared to large-cap pharma due to several factors:

Smaller company size: Smaller companies may have limited resources for research & development and face greater competition.

Volatility: The stock prices of smaller companies can fluctuate more significantly than established players.

Limited liquidity: There may be lower trading volumes for these stocks, making it harder to buy or sell them quickly.

Tax implications on capital gains from stock sales depend on the holding period. Long-term capital gains (held for over one year) on equity shares attract lower tax rates compared to short-term gains (held for less than one year).

Here are a few alternatives to consider:

• Large-cap pharma stocks: These offer potentially lower risk but may have limited growth prospects compared to smaller companies.
• Pharma mutual funds: Invest in a basket of pharma companies through a mutual fund, offering diversification and professional management.
• Exchange Traded Funds (ETFs) focusing on the pharma sector: ETFs track a specific index of pharma companies, providing diversification and ease of investment.